Invention Grant
- Patent Title: Di-substituted oxadiazoles as CXC-chemokine receptor ligands
- Patent Title (中): 二取代的恶二唑作为CXC-趋化因子受体配体
-
Application No.: US11475811Application Date: 2006-06-27
-
Publication No.: US07718678B2Publication Date: 2010-05-18
- Inventor: Purakkattle J. Biju
- Applicant: Purakkattle J. Biju
- Applicant Address: US NJ Kenilworth
- Assignee: Schering Corporation
- Current Assignee: Schering Corporation
- Current Assignee Address: US NJ Kenilworth
- Agent Henry C. Jeanette
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/433 ; C07D271/04 ; C07D271/10 ; C07D285/06 ; C07D285/12
Abstract:
Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof. X is N or N+O−, and Y is N or N+O−, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD.
Public/Granted literature
- US20070004682A1 Di-substituted oxadiazoles as CXC-chemokine receptor ligands Public/Granted day:2007-01-04
Information query
